An Update of Vaccine Therapy and Other Immunotherapeutic Approaches for Glioblastoma

Outcome for glioblastoma (GBM), the most common primary CNS malignancy, remains poor. Overall survival benefit recently achieved with immunotherapeutics for melanoma and prostate cancer support evaluation of immunotherapies for other challenging cancers including GBM. Much historical dogma depicting...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Reardon, David A., Wucherpfennig, Kai W., Freeman, Gordon, Wu, Catherine, Chiocca, E. Antonio, Wen, Patrick Y., Curry, William T., Mitchell, Duane A., Fecci, Peter, Sampson, John H., Dranoff, Glenn
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2013
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3982399/
https://ncbi.nlm.nih.gov/pubmed/23750791
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/erv.13.41
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi